Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Torrent"

51 News Found

Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr
News | July 30, 2025

Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr

Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025


Torrent Pharmaceuticals appoints Aman Mehta as MD
People | July 29, 2025

Torrent Pharmaceuticals appoints Aman Mehta as MD

Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York


Torrent Pharma launches nutrition supplement powder Shelcal Total
News | July 23, 2025

Torrent Pharma launches nutrition supplement powder Shelcal Total

Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio


Torrent Pharma to acquire KKR’s stake in JB Pharma for Rs. 25,689 Cr
News | June 29, 2025

Torrent Pharma to acquire KKR’s stake in JB Pharma for Rs. 25,689 Cr

Acquisition to be followed by merger; strengthens Torrent’s IPM market presence


Torrent Pharma reports Q4 FY25 PAT at Rs. 498 Cr
News | May 26, 2025

Torrent Pharma reports Q4 FY25 PAT at Rs. 498 Cr

The revenue witnessed a growth of 7.80 per cent on a year-on-year basis at Rs. 2,959 crore


Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr
News | January 28, 2025

Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024


Torrent Pharma inks agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
News | December 05, 2024

Torrent Pharma inks agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands

The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market


Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
News | September 27, 2024

Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test

The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious


Briefs: Dr. Reddy's Laboratories and Torrent Pharmaceuticals
Drug Approval | September 20, 2024

Briefs: Dr. Reddy's Laboratories and Torrent Pharmaceuticals

USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation


Torrent Pharmaceuticals posts Q1 FY25 consolidated PAT at Rs. 457 Cr
News | July 24, 2024

Torrent Pharmaceuticals posts Q1 FY25 consolidated PAT at Rs. 457 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024